Any use of GLP-1 agonists for binge eating disorder is off-label and should involve specialist oversight with continued psychological support
Injectable patients are taught subcutaneous self-injection technique in-office
Gene expression analysis showed upregulation of survival pathways (Egr1, Akt1, Kras, Src, Foxo, Srf, VEGFR2, NOS1, NOS3) and downregulation of inflammatory mediators (NOS2, NFB)
Wound healing studies provide additional evidence for GHK-Cus regenerative capabilities
The integrity of intervertebral disks after operative treatment of thoracolumbar fractures
Merck began trials of the HMG-CoA reductase inhibitor lovastatin in 1980, and won a historic approval in 1987-- showing the medication produced robust reductions in LDL levels